Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - IL
$ 16.0
-2.79 %
$ 18.3 B
Market Cap
-11.03
P/E
TEVA - COST OF REVENUE
Cost of Revenue TEVA - Teva Pharmaceutical Industries Limited
8.48 B
LAST VALUE
3.27%
2 YEAR CAGR
-1.94%
5 YEAR CAGR
-0.83%
10 YEAR CAGR